QQ客服 官方微博 反馈留言

浏览/检索结果: 共25条，第1-10条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs) 期刊论文 ANNALS OF PALLIATIVE MEDICINE, 2021 作者:  Si, Jinfei;  Gu, Xiaodong;  Wang, Wenxian;  Ying, Shenpeng;  Song, Zhengbo 收藏  |  浏览/下载：58/0  |  提交时间：2022/02/14 Epidermal growth factor receptor (EGFR)  uncommon mutation  compound mutation  double uncommon mutation  lung adenocarcinoma (lung AC)   Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer The REALITY Randomized Clinical Trial 期刊论文 JAMA ONCOLOGY, 2021 作者:  Lin, Yansong;  Qin, Shukui;  Li, Zhiyong;  Yang, Hui;  Fu, Wei 收藏  |  浏览/下载：57/0  |  提交时间：2022/01/25 A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors 期刊论文 TRANSLATIONAL LUNG CANCER RESEARCH, 2021 作者:  Xu, Xiaoling;  Wang, Ding;  Chen, Wei;  Li, Na;  Suwinski, Rafal 收藏  |  浏览/下载：39/0  |  提交时间：2022/02/14 Immune checkpoint inhibitor (ICI)  non-small cell lung cancer (NSCLC)  peripheral blood lymphocyte subsets   The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study 期刊论文 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021 作者:  Wang, Wenxian;  Gu, Xiaodong;  Wang, Liping;  Pu, Xingxiang;  Feng, Huijing 收藏  |  浏览/下载：27/0  |  提交时间：2022/01/10 Non-small cell lung cancer  PD-L1  Immune checkpoint inhibitor  Immune-related adverse event   Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy 期刊论文 EUROPEAN JOURNAL OF RADIOLOGY, 2021, 卷号: 142, 页码: 8 作者:  Wei, Shengcai;  Han, Yuqi;  Zeng, Hanjiang;  Ye, Shuai;  Cheng, Jin 收藏  |  浏览/下载：67/0  |  提交时间：2021/11/03 Histopathologic growth pattern  Colorectal liver metastases  Unresectable  Radiomics  Bevacizumab   Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy 期刊论文 CANCER MEDICINE, 2021, 页码: 11 作者:  Su, Qiang;  Liu, Zhenyu;  Chen, Chi;  Gao, Han;  Zhu, Yongbei 收藏  |  浏览/下载：268/0  |  提交时间：2021/11/03 biochemical recurrence-free survival  gene signature  LASSO-Cox regression  primary prostate cancer  radical therapy   Combined everolimus and endocrine therapy in advanced HR-positive, HER2-negative Chinese breast cancer patients: a retrospective study 期刊论文 ANNALS OF TRANSLATIONAL MEDICINE, 2021, 卷号: 9 作者:  Shen, Xia-Bo;  Li, Guang-Liang;  Zheng, Ya-Bing;  Chen, Zhan-Hong;  Cao, Wen-Ming 收藏  |  浏览/下载：22/0  |  提交时间：2021/11/01 Advanced breast cancer (ABC)  aromatase inhibitors (AIs)  everolimus (EVE)  fulvestrant (FUL)  retrospective study   Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients 期刊论文 NPJ PRECISION ONCOLOGY, 2021, 卷号: 5, 期号: 1, 页码: 9 作者:  Yan, Jing;  Zhang, Bin;  Zhang, Shuaitong;  Cheng, Jingliang;  Liu, Xianzhi 收藏  |  浏览/下载：35/0  |  提交时间：2021/11/02 Treatment efficacy and safety of regorafenib plus drug-eluting beads-transarterial chemoembolization versus regorafenib monotherapy in colorectal cancer liver metastasis patients who fail standard treatment regimens 期刊论文 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021 作者:  Cao, Fei;  Zheng, Jiaping;  Luo, Jun;  Zhang, Zhewei;  Shao, Guoliang 收藏  |  浏览/下载：46/0  |  提交时间：2021/08/30 Regorafenib plus DEB-TACE  CRLM  Treatment response  Prognosis  Adverse events   Liposome-paclitaxel and carboplatin combination chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma 期刊论文 CANCER RADIOTHERAPIE, 2021, 卷号: 25 作者:  Zeng, J.;  Cui, X.;  Cheng, L.;  Chen, Y.;  Du, X. 收藏  |  浏览/下载：21/0  |  提交时间：2021/08/31 Esophageal squamous cell carcinoma  Liposome-paclitaxel  Chemoradiotherapy  Toxicities